1D. B. Smith,E. S. Newlands,G. J. S. Rustin,R. H. J. Begent,S. M. Crawford,K. D. Bagshawe,L. Carruthers. A phase I/II study of the 5-HT3 antagonist GR38032F in the anti-emetic prophylaxis of patients receiving high-dose cisplatin chemotherapy[J] 1990,Cancer Chemotherapy and Pharmacology(4):291～294
